Browsing by Author Ascierto, Paolo A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trialLong, Georgina; Arance, A; Ascierto, Paolo A; Del Vecchio, M; Di Giacomo, A; Dummer, R; Dutriaux, Caroline; et al, Various; Gutzmer, R.; Rutkowski, Piotr; Schadendorf, D; Northern Clinical School: MedicineBinimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial, The Lancet Oncology, vol.18, 4, 2017,pp 435-445
2017Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trialMcNeil, Catriona; Arance, A; Ascierto, Paolo A; Bastholt, Lars; Chiarion-Sileni, Vanna; Del Vecchio, Michele; et al, Various; Hamid, Omid; Lebbe, Celeste; Mackiewicz, Andrzej; Robert, Caroline; Rutkowski, Piotr; Central Clinical School: MedicineIpilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial, The Lancet Oncology, vol.18, 5, 2017,pp 611-622